Harrow Inc. is a OTC stock, trading under the symbol HROW on the (). It is usually referred to as or HROW
In the last year, there was no coverage of Harrow Inc. published on Stockchase.
Harrow Inc. was recommended as a Top Pick by on . Read the latest stock experts ratings for Harrow Inc..
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
In the last year 0 stock analysts on Stockchase covered Harrow Inc.. The stock is worth watching.
On , Harrow Inc. (HROW) stock closed at a price of $.
It is in the eye care business and focuses on ophthalmology and biotech. One question is how easily can they get drugs to patients. Their first interesting drug is for dry eyes and the second is an anesthetic for surgeries, especially cataract surgery. This one is stable and consistent from patient to patient. Other anesthetics vary in their length of time they are effective from patient to patient. Has stable cash flows from its compounding business and accelerating growth from key products. Could get from under $300 million in revenue today to $1 billion in revenue in the next four years as well as tripling margins. Buy 8 Hold 0 Sell 0
(Analysts’ price target is $59.83)